AARHUS, DENMARK, 27 Nov 2024: Cercare Medical proudly announces that a new study led by Dr. Alexandre Bani-Sadr and his team in Lyon, published on the front page of the Stroke journal, has revealed how advanced imaging biomarkers from Cercare Medical are significantly impacting stroke patient care. This pioneering study highlights how the application of Cercare’s perfusion maps - particularly Oxygen Extraction Fraction (OEF) mapping - can predict the recovery of ischemic brain lesions following thrombectomy, marking a major step forward in stroke treatment and neurological care.
The research, titled “Oxygen Extraction Fraction Mapping on Admission Magnetic Resonance Imaging May Predict Recovery of Hyperacute Ischemic Brain Lesions After Successful Thrombectomy: A Retrospective Observational Study,” provides compelling evidence of the value of advanced perfusion maps in stroke management. The study investigates how specific biomarkers - such as OEF- can indicate the likelihood of brain tissue recovery post-thrombectomy. The findings offer clinicians a new level of precision in assessing patient outcomes and may inform critical decisions on personalized treatment plans for stroke recovery.
Innovative Use of Advanced Biomarkers
In this retrospective study, data from the HIBISCUS-STROKE cohort was analyzed to explore the relationship between OEF and recovery of brain lesions in patients who underwent thrombectomy. By comparing dynamic-susceptibility contrast perfusion MRIs with OEF maps, Dr. Bani-Sadr and his team demonstrated that patients with higher OEF levels in ischemic regions were more likely to show substantial recovery. This research provides a new layer of insight for clinicians, helping predict how the ischemic core will evolve post-intervention, an advancement that may guide more targeted therapies in stroke care.
Cercare Medical’s Contribution to Neurological Innovation
Cercare Medical’s advanced imaging tools, including Capillary Transit Time Heterogeneity (CTH) and
OEF mapping, allow for unparalleled precision in perfusion imaging. These biomarkers enable clinicians to gain a clearer view of cerebral oxygenation and tissue health in stroke patients, which is crucial for determining the most effective course of action. By integrating these technologies into stroke treatment protocols, Cercare Medical supports clinicians worldwide in delivering faster, more accurate, and highly personalized care.
About Cercare Medical:
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and
multi-vendor compatible software for CT and MRI perfusion imaging post-processing, we are
committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.
